Three-dimensional cultures (or “organoids”) derived from the tumors of cancer patients closely replicate key properties of the original tumors, reveals a study published May 7 in Cell. These “organoid” cultures are amenable to large-scale drug screens for the detection of genetic changes associated with drug sensitivity and pave the way for personalized treatment approaches that could optimize clinical outcomes in cancer patients.
“This is the first time that a collection of cancer organoids, or a living biobank, has been derived from patient tumors,” says senior study author Mathew Garnett, a geneticist at the Wellcome Trust Sanger Institute. “We believe that these organoids are an important new tool in the arsenal of cancer biologists and may ultimately improve our ability to develop more effective cancer treatments.”
To study the causes of cancer and develop new cancer treatments, many laboratories use experimental model systems such as cells grown from patient tumors. However, currently available cell lines have been derived under suboptimal conditions and therefore fail to reflect important features of tumor cells. As a result, it has been challenging to predict the drug sensitivity of individual patients based on their unique spectrum of genetic mutations.
In recent years, scientists have developed organoid cell culture systems as an alternative approach to grow normal and diseased tissue in a dish. In contrast to cell lines, organoids display the hallmarks of the original tissue in terms of its 3D architecture, the cell types present, and their self-renewal properties. Given the advantages of organoids, Garnett and Hans Clevers of the Hubrecht Institute set out to test whether these cultures could potentially bridge the gap between cancer genetics and patient outcomes.
In the new study, the researchers grew 22 organoids derived from tumor tissue from 20 patients with colorectal cancer and then sequenced genomic DNA isolated from these cultures. The genetic mutations in the organoid cultures closely matched those in the corresponding tumor biopsies and agreed well with previous large-scale analyses of colorectal cancer mutations. These findings confirm that the cultures faithfully capture the genomic features of the tumors from which they are derived as well as much of the genomic diversity associated with colorectal cancer.
To link drug sensitivity to genetic changes, the researchers next screened the responses of the organoids to 83 experimental and approved cancer drugs. Given their diverse genetic profiles, the organoids displayed a range of sensitivities to the drugs. In validation of the approach, the researchers identified previously reported associations between specific mutations and resistance to particular drugs. The organoids also revealed a novel gene-drug association, indicating that the subset of cancer patients with RNF43 mutations would strongly benefit from a drug that inhibits a protein called porcupine. “At some point in the future, this approach may be suitable for modeling individual patient response to cancer therapies to inform clinical treatment,” Garnett says.
The Latest on: Organoids
via Google News
The Latest on: Organoids
- Sergiu Pasca Builds Brains to Study Developmental Diseaseon November 30, 2019 at 9:30 pm
“It was one of the first papers showing that you can actually make human neurons from patients and identify changes,” Pasca says. He and a student in the lab also started to grow brain organoids—a ...
- Single cell census of human kidney organoids shows reproducibility and diminished off-target cells after transplantationon November 29, 2019 at 2:19 am
Human iPSC-derived kidney organoids have the potential to revolutionize discovery, but assessing their consistency and reproducibility across iPSC lines, and reducing the generation of off-target ...
- Complex Organoids From Stem Cellson November 28, 2019 at 1:03 pm
These complex 3 dimensional tumor and brain organoids which were developed in a Petri dish feature functional blood vessels, connective tissue, and in the case of brain tissues also brain specific ...
- Recreating the human brain in a lab to treat dementia and brain disorderson November 28, 2019 at 12:51 pm
Scientists in Queensland are able to grow use human cells to grow grey matter The researchers hope their work could one day help to heal brain injuries The study could also help to treat various other ...
- Graft immaturity and safety concerns in transplanted human kidney organoidson November 27, 2019 at 7:32 pm
For chronic kidney disease, regeneration of lost nephrons with human kidney organoids derived from induced pluripotent stem (iPS) cells is proposed to be an attractive potential therapeutic option. It ...
- LACV-infected cerebral organoids reveal how to protect neurons from virus-induced deathon November 26, 2019 at 12:50 pm
The NIH scientists, from the National Institute of Allergy and Infectious Diseases Rocky Mountain Laboratories in Hamilton, Montana, used cerebral organoids to model how LACV infects the human brain.
- Cells Infected with La Crosse Virus (image)on November 26, 2019 at 6:43 am
These images taken from LACV-infected cerebral organoids show infected cells (green) and cells that are dying from infection (magenta). The left image also shows neural stem cells (white) that have ...
- Australian researchers create kidney tissue from iPS cellson November 25, 2019 at 3:33 pm
The team has developed approaches for directing the differentiation of human pluripotent stem cells to human kidney organoids and is applying that knowledge to disease modeling, drug screening, cell ...
- Scientists May Have Crossed Ethical Lines In Growing Nephilim Organoidson November 24, 2019 at 5:47 am
On Monday, researchers will tell the world’s largest annual meeting of neuroscientists that some scientists working on organoids are “perilously close” to crossing the ethical line, while others may ...
- Major step taken in creating complex organs in the labon November 21, 2019 at 7:37 am
Scientists from the University of Würzburg, Germany have taken a major step towards developing functional miniature versions of human organs, known as complex organoids. Japanese researchers had ...
via Bing News